Literature DB >> 3597847

Erythrocyte sialic acid in human sickle-cell disease.

G C Onyemelukwe, K A Esievo, C N Kwanashie, A G Kulkarni, E N Obinechie.   

Abstract

Membrane-bound erythrocyte surface sialic acid concentrations in sickle-cell human patients (SS) and in control patients with sickle-cell trait (AS) and normal genes (AA) were assayed. The erythrocyte sialic acid concentration was significantly (P less than 0.001) higher in sickle-cell patients than in non-sicklers and although the concentration was higher in AS than AA individuals the difference was not significant (P greater than 0.05). The anaemic state of the SS patients was shown by a significantly (P less than 0.001) lower PCV than in non-sicklers. This finding is discussed in relation to membrane toughness and subsequent membrane loss leading to irreversible sickling of red cells in the deoxygenated state.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597847     DOI: 10.1016/0021-9975(87)90034-x

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  4 in total

1.  Erythrocyte surface sialic acid levels of clinically healthy mongrel and exotic (alsatian and terrier) breeds of dogs.

Authors:  Nicodemus M Useh; Adenike I Aina; Abubakar A Adeiza; Andrew J Nok
Journal:  Glycoconj J       Date:  2007-05-16       Impact factor: 2.916

2.  Critical role of C5a in sickle cell disease.

Authors:  Gregory M Vercellotti; Agustin P Dalmasso; Terry R Schaid; Julia Nguyen; Chunsheng Chen; Marna E Ericson; Fuad Abdulla; Trevor Killeen; Margaret A Lindorfer; Ronald P Taylor; John D Belcher
Journal:  Am J Hematol       Date:  2019-01-03       Impact factor: 10.047

3.  Characterization and statistical modeling of glycosylation changes in sickle cell disease.

Authors:  Heather E Ashwood; Christopher Ashwood; Anna P Schmidt; Rebekah L Gundry; Karin M Hoffmeister; Waseem Q Anani
Journal:  Blood Adv       Date:  2021-03-09

4.  Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease.

Authors:  Zachary M Kiser; Anel Lizcano; Julia Nguyen; Greta L Becker; John D Belcher; Ajit P Varki; Gregory M Vercellotti
Journal:  Blood Cells Mol Dis       Date:  2019-12-20       Impact factor: 3.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.